Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 26 studies | 43% ± 21% | |
endothelial cell | 24 studies | 32% ± 15% | |
smooth muscle cell | 23 studies | 34% ± 19% | |
fibroblast | 20 studies | 29% ± 11% | |
non-classical monocyte | 19 studies | 29% ± 13% | |
macrophage | 18 studies | 29% ± 12% | |
conventional dendritic cell | 13 studies | 26% ± 9% | |
classical monocyte | 10 studies | 24% ± 11% | |
connective tissue cell | 10 studies | 33% ± 13% | |
endothelial cell of vascular tree | 10 studies | 30% ± 9% | |
mast cell | 10 studies | 24% ± 5% | |
monocyte | 8 studies | 32% ± 11% | |
endothelial cell of artery | 8 studies | 29% ± 14% | |
capillary endothelial cell | 7 studies | 20% ± 4% | |
myofibroblast cell | 7 studies | 43% ± 15% | |
myeloid cell | 7 studies | 27% ± 10% | |
astrocyte | 7 studies | 23% ± 11% | |
neuron | 6 studies | 33% ± 22% | |
retinal rod cell | 6 studies | 33% ± 18% | |
basal cell | 6 studies | 35% ± 12% | |
mononuclear phagocyte | 5 studies | 34% ± 21% | |
B cell | 5 studies | 24% ± 6% | |
microglial cell | 5 studies | 23% ± 8% | |
retinal cone cell | 5 studies | 49% ± 30% | |
epithelial cell | 5 studies | 35% ± 19% | |
ciliated cell | 5 studies | 37% ± 10% | |
oligodendrocyte | 5 studies | 19% ± 4% | |
pancreatic A cell | 4 studies | 42% ± 8% | |
vein endothelial cell | 4 studies | 23% ± 7% | |
dendritic cell | 4 studies | 40% ± 14% | |
GABAergic neuron | 4 studies | 30% ± 8% | |
glutamatergic neuron | 4 studies | 40% ± 9% | |
oligodendrocyte precursor cell | 4 studies | 23% ± 6% | |
type B pancreatic cell | 3 studies | 48% ± 14% | |
glomerular endothelial cell | 3 studies | 27% ± 7% | |
leukocyte | 3 studies | 27% ± 4% | |
retinal bipolar neuron | 3 studies | 40% ± 13% | |
retinal ganglion cell | 3 studies | 73% ± 18% | |
type I pneumocyte | 3 studies | 28% ± 7% | |
amacrine cell | 3 studies | 45% ± 16% | |
retina horizontal cell | 3 studies | 37% ± 20% | |
Mueller cell | 3 studies | 47% ± 16% | |
endothelial cell of lymphatic vessel | 3 studies | 42% ± 14% | |
interneuron | 3 studies | 29% ± 9% | |
plasmacytoid dendritic cell | 3 studies | 22% ± 3% | |
enteroendocrine cell | 3 studies | 39% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 7164.18 | 2642 / 2642 | 100% | 66.11 | 705 / 705 |
esophagus | 100% | 4905.48 | 1445 / 1445 | 100% | 19.06 | 183 / 183 |
ovary | 100% | 4949.59 | 180 / 180 | 100% | 33.68 | 430 / 430 |
thymus | 100% | 6380.00 | 653 / 653 | 100% | 52.90 | 605 / 605 |
breast | 100% | 5155.16 | 459 / 459 | 100% | 42.14 | 1117 / 1118 |
kidney | 100% | 4893.24 | 89 / 89 | 100% | 48.94 | 900 / 901 |
prostate | 100% | 5047.81 | 245 / 245 | 100% | 38.99 | 501 / 502 |
uterus | 100% | 6480.98 | 170 / 170 | 100% | 34.47 | 458 / 459 |
lung | 100% | 4942.00 | 577 / 578 | 100% | 33.85 | 1154 / 1155 |
skin | 100% | 4235.01 | 1808 / 1809 | 100% | 45.10 | 471 / 472 |
bladder | 100% | 5004.76 | 21 / 21 | 100% | 27.53 | 502 / 504 |
adrenal gland | 100% | 5694.33 | 258 / 258 | 100% | 64.64 | 229 / 230 |
intestine | 100% | 5072.50 | 966 / 966 | 99% | 20.18 | 524 / 527 |
liver | 100% | 3693.12 | 225 / 226 | 100% | 26.47 | 405 / 406 |
stomach | 100% | 3507.13 | 359 / 359 | 99% | 19.38 | 283 / 286 |
pancreas | 96% | 1843.93 | 315 / 328 | 100% | 29.67 | 178 / 178 |
adipose | 100% | 5423.31 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 33.20 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 36.69 | 29 / 29 |
muscle | 100% | 7571.51 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7762.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.19 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.11 | 1 / 1 |
blood vessel | 100% | 5405.34 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 6982.85 | 928 / 929 | 0% | 0 | 0 / 0 |
heart | 100% | 4420.23 | 859 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_1902268 | Biological process | negative regulation of polyamine transmembrane transport |
GO_0090316 | Biological process | positive regulation of intracellular protein transport |
GO_0006596 | Biological process | polyamine biosynthetic process |
GO_0006595 | Biological process | polyamine metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0008073 | Molecular function | ornithine decarboxylase inhibitor activity |
Gene name | OAZ2 |
Protein name | Ornithine decarboxylase antizyme 2 Ornithine decarboxylase antizyme 2 (AZ2) (ODC-Az 2) |
Synonyms | |
Description | FUNCTION: Ornithine decarboxylase (ODC) antizyme protein that negatively regulates ODC activity and intracellular polyamine biosynthesis and uptake in response to increased intracellular polyamine levels. Binds to ODC monomers, inhibiting the assembly of the functional ODC homodimers. Does not target the ODC monomers for degradation, which allows a protein synthesis-independent restoration of ODC activity . Involved in the translocation of AZIN2 from ER-Golgi intermediate compartment (ERGIC) to the cytosol (By similarity). . |
Accessions | ENST00000559912.2 J3QLV9 J3KRW5 J3KS80 O95190 ENST00000326005.10 [O95190-1] ENST00000559753.1 ENST00000560258.6 |